Broad Institute, GNS Host Symposium to Familiarize Pharma Scientists with Network Biology

Network biology has yet to make serious inroads into the drug-development pipeline, but speakers and attendees at a recent conference indicated that the time may be ripe for pharma to give the approach a chance.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories